caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1760717425

James MayesO.D.

PRACTICEEYECARE AND EYEWEAR LLCSee all providers at this practice →
OptometryHobbs, NMI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
847
Unique beneficiaries
—
Total services
996
Distinct HCPCS
9
Medicare payment
$65K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 171 Optometry providers in NM — top quintile (cohort median 387).
REFERRAL NETWORK

Where James Mayes's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LEA REGIONAL HOSPITAL LLC4567
NOR-LEA HOSPITAL DISTRICT3356
Paul Engstrom
Ophthalmology · Roswell, NM
2576
John Kernan
Internal Medicine · Hobbs, NM
1534
Patrick Homer
Family Practice · Lovington, NM
1432
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
1217
PRESBYTERIAN MEDICAL SERVICES1121
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
Final MIPS score
20.8
Quality
31.7
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-6.50%
Individual
PRESCRIBING · PART D · 2024
Total Rx claims
368
Beneficiaries
—
Total drug cost
$18K
Distinct drugs
10
Brand share
33.4%
Top prescribed drugs
Latanoprost148 claims
Neomycin/Polymyxin B/Dexametha43 claims
Dorzolamide Hcl32 claims
Brimonidine Tartrate29 claims
Tobramycin/Dexamethasone29 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.